Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
223.1 USD | +0.65% | -2.34% | -5.64% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.64% | 1.15TCr | |
+41.79% | 5.4TCr | |
-0.56% | 4.19TCr | |
+49.62% | 4.2TCr | |
-7.20% | 2.84TCr | |
+12.59% | 2.64TCr | |
-21.51% | 1.9TCr | |
+6.92% | 1.3TCr | |
+24.91% | 1.22TCr | |
+29.60% | 1.23TCr |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- UBS Cuts Charles River Laboratories International Price Target to $215 From $250, Maintains Buy Rating